欧博网址:(www.aLLbet8.vip),欧博网址开放会员注册、代理开户、电脑客户端下载、苹果安卓下载等业务。

MIDF Research said the group has increased its profitability in the last few months as demand for pharmaceutical products continued to rise well into the second half of the year.

KUALA LUMPUR: Pharmaniaga Bhd is expected to post positive earnings in financial years 2022 (FY22) and FY23 as demand for pharmaceutical products continues to increase.

In a note, MIDF Research said the group has increased its profitability in the last few months as demand for pharmaceutical products continued to rise well into the second half of the year.

“Despite having no problems with raw materials, Pharmaniaga has stated that the high demand has caused manufacturing to go beyond 100% capacity, and paracetamol production had increased to more than twice the normal capacity.

“Liquid drugs are also facing a demand and supply imbalance, as such, Pharmaniaga’s Indonesian plants have been requested to deliver the syrups,” the research house pointed out.

,

皇冠体育注册平台www.hg108.vip)是一个开放皇冠体育即时比分、皇冠体育官网注册的平台。皇冠体育注册平台(www.hg108.vip)专业解决皇冠体育会员怎么申请开户、怎么申请皇冠体育信用盘代理、皇冠体育公司的代理怎么拿的问题。

,

MIDF Research also added that Pharmaniaga’s logistics segment will be renewing its concession agreement with the government in the fourth quarter of 2022, assuring a steady order of drugs for public hospitals in the near term.

Additionally, the group’s efforts to push its brands to become household names could reset the public sentiment that only certain brands of drugs would give out the same effect, hence boosting its future income.

“We are also optimistic on its vending machine venture which is part of the pharmaceutical sector’s solution to accessibility and digital healthcare,” it said. — Bernama


转载说明:本文转载自Sunbet。 Allbet Gaming声明:该文看法仅代表作者自己,与www.allbetgame.us无关。转载请注明:欧博网址(www.aLLbet8.vip):Pharmaniaga to ride on high demand for its products
发布评论

分享到:

Telegram群发消息(www.tel8.vip):Unitrade proposes 30% dividend payout for FY22
你是第一个吃螃蟹的人
发表评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。